Edition:
United States

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

0.41USD
18 Jan 2019
Change (% chg)

$-0.00 (-0.37%)
Prev Close
$0.41
Open
$0.45
Day's High
$0.45
Day's Low
$0.40
Volume
31,849
Avg. Vol
81,934
52-wk High
$3.30
52-wk Low
$0.27

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 37.16 -0.891
Jun '18 21.09 -1.134
Mar '18 28.14 -1.566
FY 2017 Dec '17 41.54 -2.797
Sep '17 40.47 0.385
Jun '17 34.32 -2.158
Mar '17 29.74 -2.941
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.48 33.71
P/E High - Last 5 Yrs. -- 45.02 49.93
P/E Low - Last 5 Yrs. -- 23.66 24.27
Beta 1.69 0.90 0.90
Price to Sales (TTM) 0.26 4.12 6.28
Price to Book (MRQ) -- 5.11 5.27
Price to Tangible Book (MRQ) -- 5.85 6.79
Price to Cash Flow (TTM) -- 24.01 24.84
% Owned Institutions 21.30 0.91 1.69

Dividends

  Company industry sector
Dividend Yield -- 1.49 1.40
Dividend Yield - 5 Year Avg -- 1.51 1.42
Dividend 5 Year Growth Rate -- 4.13 4.83
Payout Ratio(TTM) -- 43.96 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -6.61 4.30 9.72
Sales (TTM) vs TTM 1 Yr. Ago -17.36 4.14 5.87
Sales - 5 Yr. Growth Rate 18.37 10.87 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago 53.78 45.04 47.26
EPS (TTM) vs TTM 1 Yr. Ago 29.25 -- --
EPS - 5 Yr. Growth Rate -- 10.28 10.82
Capital Spending - 5 Yr. Growth Rate 41.15 15.84 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.67 2.15 2.26
Current Ratio (MRQ) 0.75 2.98 3.08
LT Debt to Equity (MRQ) -- 8.86 11.38
Total Debt to Equity (MRQ) -- 12.90 16.13
Interest Coverage (TTM) -9.29 33.85 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 70.21 53.65 53.78
Gross Margin - 5 Yr. Avg. 64.57 51.65 52.17
EBITD Margin (TTM) 4.02 -- --
EBITD - 5 Yr. Avg -0.57 17.95 12.87
Operating Margin (TTM) -93.55 14.28 6.20
Operating Margin - 5 Yr. Avg. -56.18 14.22 8.31
Pre-Tax Margin (TTM) -120.18 14.84 7.17
Pre-Tax Margin - 5 Yr. Avg. -69.72 14.67 8.61
Net Profit Margin (TTM) -120.56 11.08 3.30
Net Profit Margin - 5 Yr. Avg. -65.04 11.02 4.88
Effective Tax Rate (TTM) -- 23.02 22.88
Effective Tax Rate - 5 Yr. Avg. -- 23.17 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 733,508 959,798,954 844,239,694
Net Income/Employee (TTM) -884,286 113,819,313 100,064,161
Receivable Turnover (TTM) 2.90 5.72 5.72
Inventory Turnover (TTM) 4.45 2.61 3.48
Asset Turnover (TTM) 0.42 0.97 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -50.40 11.55 11.08
Return on Assets - 5 Yr. Avg. -23.23 12.93 12.21
Return on Investment (TTM) -74.47 14.98 14.48
Return on Investment - 5 Yr. Avg. -31.36 16.85 15.88
Return on Equity (TTM) -- 16.31 15.99
Return on Equity - 5 Yr. Avg. -138.91 17.77 17.00
  1 Year 3 Year 5 Year
Sales % -19.90 18.40 18.37
EPS (TTM) % 22.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pernix Therapeutics Holdings Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 1.68 -1.82 49 22
13 Week -21.56 -25.38 13 39
26 Week -19.03 -25.19 24 33
52 Week -49.29 -57.02 9 9
YTD 55.67 36.71 86 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 15.78%
# of Holders: 40
Total Shares Held: 2,288,407
3 Mo. Net Change: -703,289
# New Positions: 1
# Closed Positions: 2
# Increased Positions: 1
# Reduced Positions: 2
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.